Class Attys Want OK Of $1B Deal To End Vioxx Marketing Row
Class attorneys for Merck & Co. Inc. shareholders that reached a $1.06 billion deal with the pharmaceutical giant to resolve multidistrict litigation over the alleged illegal marketing of Vioxx on Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article